Renzo Cordera

Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial

Olga Vaccaro, Maria Masulli, Antonio Nicolucci et al. · The Lancet Diabetes & Endocrinology · 2017 · 285 citations

Diabetes Management, Cardiovascular Disease, Diabetes +9

Direct inhibition of hexokinase activity by metformin at least partially impairs glucose metabolism and tumor growth in experimental breast cancer

Cecilia Marini, Barbara Salani, Michela Massollo et al. · Cell Cycle · 2013 · 142 citations · Full text

Biochemistry, Hexokinase Activity, Tumor Growth +14

Metformin Impairs Glucose Consumption and Survival in Calu-1 Cells by Direct Inhibition of Hexokinase-II

Barbara Salani, Cecilia Marini, Alberto Del Río et al. · Scientific Reports · 2013 · 119 citations · Full text

Insulin-like growth factor-1 and angiographically documented coronary artery disease

Paolo Spallarossa, Claudio Brunelli, Francesco Minuto et al. · The American Journal of Cardiology · 1996 · 113 citations

Metabolic Syndrome, Vascular Disease, Cardiovascular Disease +7

Effect of metformin treatment on insulin action in diabetic rats: In vivo and in vitro correlations

Luciano Rossetti, Ralph A. DeFronzo, Roberto Gherzi et al. · Metabolism · 1990 · 110 citations · Full text